Press release
Branded Generics Market Analysis, Opportunities With Novartis, Lupin Pharmaceuticals, Allergan, Aurobindo Pharma, Teva Pharmaceuticals, Aspen Pharma, Cipla, Abbott, STADA, Mylan, Sun Pharmaceutical
Branded Generics
The overviews, SWOT analysis and strategies of each vendor in the market is provided in this report to help better understanding about the market forces and how those can be exploited to create future opportunities. This branded generics market report provides pin point analysis for changing competitive dynamics. It presents a six year forecast assessed on the basis of how the market is predicted to grow.
Get Free Sample of This Market Information: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-branded-generics-market
Global branded generics market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026. This rise in market value can be attributed to growing need for cheaper treatment options and pharmaceutical drugs required by patients.
Key Market Competitors: Global Branded Generics Market
Teva Pharmaceutical Industries Ltd.; Zydus Cadila; Hetero; AstraZeneca; Mylan N.V.; Novartis AG; Pfizer Inc.; GlaxoSmithKline plc; Aspen Holdings; Bausch Health; Eris Lifesciences Limited; Par Pharmaceutical; Sanofi; Apotex Inc.; Dr. Reddy’s Laboratories Ltd.; Abbott; Sun Pharmaceutical Industries Ltd.; Lupin Pharmaceuticals, Inc.; ALLERGAN; Stada Arzneimittel; Cipla Inc. and EVA PHARMA are few of the major competitors currently working in the branded generics market.
Market Drivers:
Growth in the number of patents expired and expiring for the branded drugs; this factor is one of the major factors driving the market growth
Growth in the incidents and population suffering from chronic diseases and disorders; this factor is expected to drive the market growth
Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-branded-generics-market
Segmentation: Global Branded Generics Market
Product Type - Value-Added Branded Generics, Trade Named Generics
Therapeutic Application - Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, Others
Drug Class - Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic, Others
Consumption Type - Oral, Parenteral, Topical, Others
Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Geography
North America (U.S., Canada, Mexico)
South America (Brazil, Argentina, Rest of South America)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe)
Asia-Pacific ( Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific)
Middle East & Africa (South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, Rest of Middle East & Africa)
Key Developments in the Market:
In January 2019, Hetero announced the launch of generic version of “lapatinib” in India, which will be commercialized as “Hertab” by Hetero Healthcare Ltd.
In February 2018, Hetero announced the launch of a generic fixed-dose combination (FDC) drug of “emtricitabine” and “tenofovir alafenamide” in India. The product has already been approved by Drug Controller General of India (DCGI) will be commercialized as “Tafero-EM” by Hetero Healthcare Ltd.
In November 2017, Eris Lifesciences Limited announced that they had agreed to acquire the branded generics division of Strides Shasun Limited. This acquisition will help in establishing Eris Lifesciences Limited as one of the top ten companies worldwide for Central Nervous System treatment segment.
Want Full Report? Enquire Here: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-branded-generics-market
Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com
About Us
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing Corporatesales@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Branded Generics Market Analysis, Opportunities With Novartis, Lupin Pharmaceuticals, Allergan, Aurobindo Pharma, Teva Pharmaceuticals, Aspen Pharma, Cipla, Abbott, STADA, Mylan, Sun Pharmaceutical here
News-ID: 1818629 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Generics
Branded Generics Market: An In-depth Analysis
The pharmaceutical industry has long been a cornerstone of global healthcare, providing essential medications that save lives and improve quality of life. Within this vast sector, branded generics play a pivotal role, offering a unique blend of brand trust and cost-effectiveness. This article delves into the branded generics market, exploring its size, share, evolution, trends, and the factors driving its growth.
Introduction
Branded generics are off-patent drugs that are marketed under a…
A Complete Guide to Specialty Generics
The Specialty Generics Market is estimated to accelerate growth in the forecast period owing to driving factors such as the introduction of cost-effective drugs for the treatment of multiple sclerosis, cancer, and other infectious diseases, rise in the number of an off-patent specialty drug, early patent expirations are expected to boost the entry of new generics.
Grab PDF to Know More: - https://www.theinsightpartners.com/brochure/TIPRE00021203?utm_source=OpenPR&utm_medium=10209
Specialty generics are generic versions of specialty drugs…
Japan Generics Drug Market Japan Generics Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Japan Generic Drug Market
1.1 Reasons for Growth of Japan Generic Market
1.2 Some Misconceptions Related to Generic Drugs in Japan
2. Attractiveness of Japan Generic Market
2.1 Overview of Japan Pharmaceutical Market
2.2 Features of Japan Generic Drugs Market
2.3 Generic Drug Firms in Japan
2.4 Generic Drugs Import in Japan
…
Japan Generics Drug Market Outlook 2020
Japan is a small island nation located in East Asia and it is known for its economic prosperity. It sports one of the largest pharmaceutical markets like US and Europe due to which immense commercialization opportunities are present. Unique demographic structure and presence of advanced technology is the main reason for the growth of Japanese pharmaceutical industry. They have one of the most advanced research and development facilities across the…
US Cancer Generics Market Outlook 2022
“US Cancer Generics Market Outlook 2022” report gives comprehensive insight on the various indicators and trend analysis related to the emergence and integration of cancer generics drugs in mainstream pharmaceutical market in US. The report analyzes various clinical and non-clinical parameters responsible for the growth on cancer generics drugs in recent years. The introduction of generics has resulted in saving of billions of dollars for various stake holders involved US…
Global Cancer Generics Market Forecast to 2022
ReportsWorldwide has announced the addition of a new report title Global Cancer Generics Market Forecast to 2022 to its growing collection of premium market research reports.
Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the rising incidences of cancer. In 2015, 15.2 Million new cancer cases were registered across the globe. This number is forecasted to increase to a value of 19.3 Million by…
